Meet Lilly at BIO 2025

lilly

 

At Lilly, we take smart risks on bold science to discover treatments and cures, all for one reason – patients. As a community of scientists, we recognize our responsibility as partners to help advance innovative medicines within our organization and beyond it. We understand that every partnership is unique – with distinctive aspects such as the stage, modality, therapeutic area, and culture. We have the necessary skills, capabilities, and know-how to bring a complete range of models to life and meet your specific needs. We approach every partnership with confidence, thoughtfulness, and enthusiasm. Together, we can make a difference in the lives of patients around the world. 

Lilly is mainly looking for opportunities to work with external partners in the following scientific areas: Diabetes, Obesity and Cardiometabolic Diseases, Immunology, Neuroscience, Oncology, Adjacent Therapeutic Areas Indications, Emerging Technology and Platforms (including Genetic Medicines and Molecule Innovation), Health Tech, Diagnostics, Drug Delivery, R&D Tools, and Manufacturing, and Biotechnology Discovery Research. 

 

Log in to BIO Partnering™ to send us a meeting request.

LOG IN

Adrienne Brown

Group VP - Head of Corporate Business Development

“At Lilly, our mission is clear: to put patients at the heart of everything we do. Through our Corporate Business Development team, we build partnerships that push boundaries, turning bold science into transformative healthcare solutions. Together, we create opportunities from challenges and drive life-saving innovations that improve lives worldwide—one partnership at a time.” 

Nisha Nanda

Group VP - Business Development, Head of Lilly Catalyze360

“Catalyze360 doesn’t just partner with biotech companies—we walk alongside them, supporting them every step of their journey. We offer a comprehensive suite of resources, including access to funding through Lilly Ventures, cutting-edge lab space, technology, and mentorship at Lilly Gateway Labs, and the unmatched expertise of our R&D team via ExploR&D. Our collaborations are built on a shared vision and unified mission to accelerate science into meaningful solutions for patients around the world. Together, we pave the way for tomorrow’s breakthroughs.” 

CORPORATE BUSINESS DEVELOPMENT

Jake Shuman 

VP - Global Head of Transactions and M&A 

Wanda Rutledge-Gordon 

VP - Global Head of Alliance and Innovation Management 

CATALYZE360 

Brad Robling  

VP - Global Head of Lilly Ventures 

Jim MacKrell 

VP - Lilly Ventures

Julie Gilmore 

VP - Global Head of Lilly Gateway Labs 

Tom Hopkins 

VP - Global Head of Lilly ExploR&D 

SEARCH & EVALUATION 

Benjamin Yaden 

VP - Global Head Diabetes, Obesity and Cardiometabolic Diseases Search & Evaluation 

David Shrom 

VP - Global Head Immunology Search & Evaluation 

Jenny Laird 

VP - Global Head Neuroscience (Neurology and Pain) Search & Evaluation 

Hallee Foster 

VP - Global Head Neuroscience (Psychiatry) Search & Evaluation 

SEARCH & EVALUATION 

Tyler Robinson 

VP - Global Head Oncology Search & Evaluation 

Christalyn Rhodes 

VP - Global Head Genetic Medicine Search & Evaluation 

Andrew Korytko 

VP - Molecule Innovation (Biologics) Search & Evaluation 

Jim Koers 

Executive Director - CMC for Business Development